Listed

Kennametal Inc: Form 10-Q for the period ended Mar 31, 2025

Filed with the SEC on May 7, 2025 and accepted by EDGAR at May 7, 2025, 15:19 ET.

Share

Management's discussion and analysis

As filed, 5,497 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

OVERVIEW

Kennametal Inc. was founded based on a tungsten carbide technology breakthrough in 1938. The Company was incorporated in Pennsylvania in 1943 as a manufacturer of tungsten carbide metal cutting tooling and was listed on the New York Stock Exchange (NYSE) in 1967. With more than 85 years of materials expertise, the Company is a global industrial technology leader, helping customers across the Aerospace & Defense, Earthworks, Energy, General Engineering and Transportation industries manufacture with precision and efficiency. This expertise includes the development and application of tungsten carbides, ceramics, super-hard materials and solutions used in metal cutting and extreme wear applications to keep customers up and running longer against conditions such as corrosion and high temperatures.

Our standard and custom product offering spans metal cutting and wear applications including turning, milling, hole making, tooling systems and services, as well as specialized wear components and metallurgical powders. End users of the Company's metal cutting products include manufacturers engaged in a diverse array of industries including: the manufacturers of transportation vehicles and components, machine tools and light and heavy machinery; airframe and aerospace components; and energy-related components for the oil and gas industry, as well as power generation. The Company’s wear and metallurgical powders are used by producers and suppliers in equipment-intensive operations such as road construction, mining, quarrying, oil and gas exploration, refining, production and supply, and for aerospace and defense.

Throughout MD&A, we refer to measures used by management to evaluate performance. We also refer to a number of financial measures that are not defined under accounting principles generally accepted in the United States of America (U.S. GAAP), including organic sales growth (decline), constant currency regional sales growth (decline) and constant currency end market sales growth (decline). We provide the definitions of these non-GAAP financial measures at the end of the MD&A section as well as details on the use and derivation of these financial measures.

Our sales of $486.4 million for the three months ended March 31, 2025 decreased 6 percent from $515.8 million in the prior year quarter, reflecting an organic sales decline of 3 percent and an unfavorable currency exchange effect of 3 percent.

Operating income for the three months ended March 31, 2025 was $44.1 million compared to $35.2 million in the prior year quarter. The year-over-year increase of $8.8 million was primarily due to an advanced manufacturing production credit under the Inflation Reduction Act of approximately $10 million within the Infrastructure segment, lower raw material costs, pricing, and incremental year-over-year restructuring savings of approximately $6 million. These factors were partially offset by lower sales and production volumes, higher wages and general inflation and an unfavorable currency exchange effect of approximately $3 million.

Operating margin for the three months ended March 31, 2025 was 9.1 percent compared to 6.8 percent in the prior year quarter. The Metal Cutting and Infrastructure segments had operating margins of 8.2 percent and 10.7 percent, respectively, for the three months ended March 31, 2025.

Uncertainties with respect to evolving global trade policies and tariffs have negatively affected the global economy. We are currently estimating a potential exposure of approximately $80 million related to additional tariffs on an annual basis. The Company's results of operations, cash flows and financial condition could be negatively impacted by a decrease in demand for our products or an inability to effectively mitigate tariff-related cost increases through pricing and sourcing strategies. These factors could also increase the potential for future impairment charges, including goodwill and other intangible asset impairments. We continue to monitor the situation and are working to mitigate any negative impacts from tariffs.

Additionally, our business has been negatively affected by foreign currency exchange and inflationary headwinds. We have been able to partially mitigate the effects of inflation, foreign currency exchange challenges and other disruptions through price increases on our products. We cannot predict the ultimate effect of these issues on our business, operating results or financial condition, but we will continue to monitor macroeconomic conditions and attempt to mitigate the negative effect to the extent possible.

For the three months ended March 31, 2025, earnings per diluted share (EPS) was $0.41 compared to EPS of $0.24 in the prior year quarter. EPS for the three months ended March 31, 2025 was unfavorably affected by restructuring and related charges of $0.06 per share.

Net cash flow provided by operating activities was $129.7 million during the nine months ended March 31, 2025 compared to $163.5 million during the prior year period. Capital expenditures were $67.5 million and $84.2 million during the nine months ended March 31, 2025 and 2024, respectively. During the nine months ended March 31, 2025, the Company returned $101.7 million to shareholders through $55.1 million in share repurchases and $46.6 million in dividends. The Company has a long history of consistently paying dividends to shareholders since its listing on the New York Stock Exchange in 1967.

Controls and procedures

As filed, 2,064 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

As of the end of the period covered by this Quarterly Report on Form 10-Q, the Company's management evaluated, with the participation of the Company's Chief Executive Officer and Chief Financial Officer, the effectiveness of the Company's disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)). The Company's disclosure controls were designed to provide a reasonable assurance that information required to be disclosed in reports that we file or submit under the Securities Exchange Act of 1934, as amended (Exchange Act), is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission. It should be noted that the design of any system of controls is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions, regardless of how remote. However, the controls have been designed to provide reasonable assurance of achieving the controls' stated goals. Based on that evaluation, the Company's Chief Executive Officer and Chief Financial Officer have concluded that the Company's disclosure controls and procedures are effective to provide reasonable assurance at March 31, 2025 that information required to be disclosed in the reports that we file or submit under the Exchange Act is (i) accumulated and communicated to management, including the Company's Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure and (ii) recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission.

There were no changes in the Company's internal control over financial reporting that occurred during the Company's most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2025-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2025-01-01 to 2025-03-31$486.4mus-gaap:Revenues
Revenue9 months2024-07-01 to 2025-03-31$1.45bnus-gaap:Revenues
Cost of revenue3 months2025-01-01 to 2025-03-31$330.0mus-gaap:CostOfGoodsAndServicesSold
Cost of revenue9 months2024-07-01 to 2025-03-31$998.0mus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2025-01-01 to 2025-03-31$156.4mus-gaap:GrossProfit
Gross profit9 months2024-07-01 to 2025-03-31$452.4mus-gaap:GrossProfit
Operating income3 months2025-01-01 to 2025-03-31$44.1mus-gaap:OperatingIncomeLoss
Operating income9 months2024-07-01 to 2025-03-31$111.8mus-gaap:OperatingIncomeLoss
Interest expense3 months2025-01-01 to 2025-03-31$6.2mus-gaap:InterestExpenseNonoperating
Interest expense9 months2024-07-01 to 2025-03-31$18.7mus-gaap:InterestExpenseNonoperating
Income tax3 months2025-01-01 to 2025-03-31$10.2mus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2024-07-01 to 2025-03-31$26.1mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2025-01-01 to 2025-03-31$31.5mus-gaap:NetIncomeLoss
Net income9 months2024-07-01 to 2025-03-31$71.5mus-gaap:NetIncomeLoss
Diluted EPS3 months2025-01-01 to 2025-03-31$0.41us-gaap:EarningsPerShareDiluted
Diluted EPS9 months2024-07-01 to 2025-03-31$0.91us-gaap:EarningsPerShareDiluted
Basic EPS3 months2025-01-01 to 2025-03-31$0.41us-gaap:EarningsPerShareBasic
Basic EPS9 months2024-07-01 to 2025-03-31$0.92us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2025-01-01 to 2025-03-3177,651,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2024-07-01 to 2025-03-3178,208,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2024-07-01 to 2025-03-31$129.7mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure9 months2024-07-01 to 2025-03-31$67.5mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid9 months2024-07-01 to 2025-03-31$46.6mus-gaap:PaymentsOfDividendsCommonStock
Share repurchases9 months2024-07-01 to 2025-03-31$55.1mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2025-03-31$97.5mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2025-03-31$1.01bnus-gaap:AssetsCurrent
Total assetsAt period end2025-03-31$2.49bnus-gaap:Assets
Current liabilitiesAt period end2025-03-31$415.6mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2025-03-31$1.21bnus-gaap:Liabilities
Shareholders' equityAt period end2025-03-31$1.24bnus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0000055242-25-000046. Last ingested by Listed: Nov 9, 2026, 23:14 ET. Listed shows no prices and gives no investment advice.